Vitamin B12 deficiency can present symptoms indistinguishable from normal ageing — fatigue, cognitive decline, and reduced energy — yet the condition remains underdiagnosed in clinical practice. Emerging research suggests that B12 plays a critical role in maintaining mitochondrial function, the cellular mechanisms responsible for energy production, which may explain why some patients experience these symptoms before conventional laboratory markers of deficiency appear.
Key takeaways
- Vitamin B12 deficiency symptoms (fatigue, brain fog) can mimic normal ageing and may precede traditional diagnostic markers
- B12 is essential for mitochondrial function, the cellular powerhouses that generate energy; dysfunction contributes to unexplained fatigue
- Pernicious anaemia, a B12 absorption disorder, was first treated with liver therapy nearly 100 years ago; today’s understanding of B12 metabolism has expanded significantly
- Early screening and intervention for B12 deficiency may prevent progression to irreversible neurological complications
B12 deficiency symptoms often attributed to normal ageing
Common presenting features in patients with undiagnosed B12 deficiency, compared to expected age-related changes
Source: Compiled from clinical presentations in B12 deficiency literature | Georgian Medical Journal News
From pernicious anaemia to mitochondrial biology: a century of B12 research
Vitamin B12, or cobalamin, was first isolated in the 1930s as the curative agent in liver therapy for pernicious anaemia, a potentially fatal autoimmune condition in which the stomach cannot absorb B12 from food. This discovery represented a watershed moment in clinical medicine — patients who would otherwise progress to death now survived with regular B12 supplementation. The condition, caused by autoimmune destruction of intrinsic factor (the protein required for B12 absorption), remains one of the most important causes of B12 deficiency worldwide.
However, modern understanding of B12’s physiological role has expanded far beyond its historical association with pernicious anaemia. Contemporary biochemistry has revealed that B12 functions as a coenzyme in two critical metabolic pathways: the conversion of methylmalonyl-coenzyme A to succinyl-coenzyme A (via methylmalonyl-CoA mutase), and the remethylation of homocysteine to methionine (via methionine synthase). Both pathways are essential for energy metabolism, myelin formation, and DNA synthesis — processes directly relevant to cellular ageing and neurological function.
The mitochondrial hypothesis: why B12 deficiency feels like accelerated ageing
The emerging focus on mitochondrial dysfunction in B12 deficiency offers a mechanistic explanation for why patients often experience fatigue and cognitive slowing before traditional serum B12 levels fall below diagnostic thresholds. Mitochondria, the cellular organelles responsible for ATP (energy) production, rely on intact metabolic pathways that require B12-dependent cofactors. When B12 availability declines, impaired methylation and energy metabolism at the mitochondrial level can compromise cellular energy production before systemic signs emerge.
This hypothesis helps explain a clinically important observation: some patients with normal or low-normal serum B12 levels nonetheless exhibit elevated methylmalonic acid and homocysteine — functional markers of B12 insufficiency at the cellular level. These patients may develop symptoms of fatigue and brain fog that are easily misattributed to normal ageing, depression, or other age-related conditions. The result is significant diagnostic delay and prolonged suffering, as symptoms are normalised rather than investigated.
Research from the American Journal of Clinical Nutrition has documented that subclinical B12 deficiency — defined by elevated metabolic markers despite normal serum levels — affects a substantial proportion of older adults and certain high-risk populations (vegans, those with gastrointestinal disorders, and patients on metformin or proton pump inhibitors). Early intervention based on metabolic markers rather than serum B12 alone may prevent progression to frank neurological complications, including irreversible peripheral neuropathy and cognitive decline.
Risk populations and screening imperatives
Certain groups face disproportionate risk of B12 deficiency and warrant systematic screening, according to guidelines from the American Geriatrics Society. Older adults (age 65+) are at higher risk due to reduced gastric acid secretion, which impairs the release of B12 from food proteins. Vegetarians and vegans lack dietary B12 entirely, as the vitamin is synthesised by bacteria and found almost exclusively in animal products. Patients with inflammatory bowel disease, coeliac disease, or history of gastric surgery have compromised intestinal absorption. Long-term users of metformin (diabetes) or proton pump inhibitors (reflux) have altered gastric pH and intrinsic factor production, reducing B12 absorption.
The clinical implication is clear: routine serum B12 measurement should be part of the diagnostic workup for any patient presenting with unexplained fatigue, cognitive decline, or neurological symptoms — particularly in older adults where such symptoms are often dismissed as “normal ageing.” Measurement of plasma methylmalonic acid and homocysteine can identify functional B12 insufficiency even when serum B12 is borderline. Intervention with B12 supplementation (oral, intramuscular, or intranasal) can reverse early symptoms and prevent progression to irreversible neuropathy.
Implications for clinical practice and public health
The recognition that B12 deficiency can masquerade as normal ageing has immediate clinical significance. First, it argues for lowering the diagnostic threshold for investigation: any patient over 60 with new-onset fatigue or cognitive complaints warrants B12 screening, regardless of apparent dietary adequacy. Second, it supports the case for targeted screening in high-risk populations (vegans, metformin users, those with gastrointestinal disease) rather than waiting for symptoms to develop. Third, it underscores the importance of using functional metabolic markers (methylmalonic acid, homocysteine) alongside serum B12, as these better reflect cellular B12 status.
At the policy level, this research raises questions about the adequacy of current dietary guidelines for B12, particularly in ageing populations where absorption declines naturally with age. The National Institutes of Health (NIH) recommends that adults over 50 obtain B12 from fortified foods or supplements rather than relying on food sources alone — a recommendation supported by the emerging mitochondrial biology evidence. Public health campaigns emphasising B12 screening in older adults could prevent significant morbidity and improve quality of life in a cost-effective manner.
B12 deficiency causes functional mitochondrial impairment that produces fatigue and cognitive slowing before conventional diagnostic markers appear, suggesting that early detection based on metabolic markers rather than serum B12 alone may prevent progression to irreversible neurological complications.
— Research synthesis, GMJ News analysis of contemporary B12 and mitochondrial metabolism literature
What this means
Frequently asked questions
How much vitamin B12 do I need daily?
Adults aged 14 and older require 2.4 micrograms of B12 daily, according to the NIH Office of Dietary Supplements. However, only a fraction of dietary B12 is absorbed in any single meal, and absorption declines with age. Adults over 50 are advised to obtain B12 from fortified foods or supplements to ensure adequate bioavailability.
What are the first signs of B12 deficiency?
Early symptoms often include persistent fatigue unrelieved by rest, difficulty concentrating or “brain fog,” mild mood changes, and reduced physical endurance. These symptoms develop gradually over weeks to months and are easily attributed to stress, depression, or normal ageing. More specific signs include a red or swollen tongue (glossitis), mouth ulcers, or a distinctive burning sensation in the feet (paresthesias). By the time obvious neurological symptoms appear, cellular damage may already be advanced.
Can B12 deficiency cause permanent damage?
Yes. Prolonged B12 deficiency can cause irreversible damage to the spinal cord (subacute combined degeneration) and peripheral nerves, leading to chronic numbness, weakness, or loss of coordination. These neurological complications are preventable if B12 deficiency is identified and treated early. This is why early screening and intervention — before irreversible symptoms develop — is clinically critical. Once subacute combined degeneration occurs, some neurological damage may persist even after B12 replacement.
The growing recognition that B12 deficiency presents as accelerated ageing underscores a broader principle in gerontological medicine: what appears to be normal ageing often reflects treatable metabolic or nutritional insufficiency. As understanding of B12’s role in mitochondrial function deepens, clinical practice and screening recommendations are likely to shift toward earlier, more aggressive detection and intervention in high-risk populations. For patients and clinicians alike, the message is clear: unexplained fatigue and cognitive decline warrant investigation, not resignation to the assumption that they are inevitable features of growing older. For more information on age-related health conditions and evidence-based screening, see our coverage of clinical updates and new studies.
Source: This common vitamin deficiency can mimic normal aging
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
